Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension

Published:2022-04 Issue: Volume:Volume 16 Page:1261-1279
ISSN:1177-5483
Container-title:Clinical Ophthalmology
language:en
Short-container-title:OPTH

Author:

Matsuo Masato^ORCID,Matsuoka Yotaro,Tanito Masaki

Publisher

Informa UK Limited

Subject

Ophthalmology

Reference65 articles.

1. Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 – 2010: A Meta-Analysis

2. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis

3. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study

4. An Evidence-Based Review of Prognostic Factors for Glaucomatous Visual Field Progression

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3);American Journal of Ophthalmology;2024-07

2. Activation of the PGE2–EP2 pathway as a potential drug target for treating eosinophilic rhinosinusitis;Frontiers in Immunology;2024-07-01

3. Effect of Bromfenac on Reducing Neuroinflammation in an Ischemia–Reperfusion Glaucoma Model;Cells;2024-06-17

4. Intraocular pressure lowering effect of Omidenepag Isopropyl in Glaucoma: Comparing between Normal-Tension Glaucoma and Primary Open-Angle Glaucoma;2024-06-14

5. Clinical Staging of Prostaglandin-Associated Periorbitopathy Syndrome in Glaucoma: A Review from Asia;Seminars in Ophthalmology;2024-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3